Company: DK
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001628280-25-050541
Chunk: 234

Company: Delek US Holdings, Inc.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 8
Chunk 234
---
. These amounts exclude amounts related to discontinued operations of $1.4 million and $1.6 million for the three and nine months ended September 30, 2024, respectively. As of September 30, 2025, there was $38.1 million of total 

35 |

Notes to Condensed Consolidated Financial Statements (unaudited)

unrecognized compensation cost related to non-vested share-based compensation arrangements, which is expected to be recognized over a weighted-average period of 1.7 years. We issued net shares of common stock of 82,161 and 558,645 as a result of exercised or vested equity-based awards during the three and nine months ended September 30, 2025, respectively, and 59,485 and 506,524 for the three and nine months ended September 30, 2024, respectively. These amounts are net of 79,910 and 273,550 shares withheld to satisfy employee tax obligations related to the exercises and vesting during the three and nine months ended September 30, 2025, respectively, and 21,881 and 224,973 shares during the three and nine months ended September 30, 2024, respectively.

19.  Shareholders' Equity

DividendsFor 2025, our Board of Directors declared the following dividends:Approval DateDividend Amount Per ShareRecord DatePayment DateFebruary 18, 2025$0.255March 3, 2025March 10, 2025April 29, 2025$0.255May 12, 2025May 19, 2025July 30, 2025$0.255August 11, 2025August 18, 2025October 29, 2025$0.255November 10, 2025November 17, 2025Stock Repurchase Program Our Board of Directors has authorized a share repurchase program under which repurchases of Delek common stock may be executed through open market transactions or privately negotiated transactions, in accordance with applicable securities laws. The timing, price, and size of repurchases are made at the discretion of management and will depend on prevailing share prices, general economic and market conditions, and other considerations. The authorization has no expiration date. During the three and nine months ended September 30, 2025, 559,933 and 3,254,403, respectively, shares of our common stock were repurchased and cancelled at